{"nct_id":"NCT05645107","title":"A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma","status":"RECRUITING","status_verified_date":"2025-04","start_date":"2022-12-26","start_date_type":"ACTUAL","primary_completion_date":"2026-05","primary_completion_date_type":"ESTIMATED","completion_date":"2026-06","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GRFS"]}